1. Home
  2. CVRX vs DOMO Comparison

CVRX vs DOMO Comparison

Compare CVRX & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • DOMO
  • Stock Information
  • Founded
  • CVRX 2000
  • DOMO 2010
  • Country
  • CVRX United States
  • DOMO United States
  • Employees
  • CVRX N/A
  • DOMO N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DOMO Computer Software: Prepackaged Software
  • Sector
  • CVRX Health Care
  • DOMO Technology
  • Exchange
  • CVRX Nasdaq
  • DOMO Nasdaq
  • Market Cap
  • CVRX 337.5M
  • DOMO 286.1M
  • IPO Year
  • CVRX 2021
  • DOMO 2018
  • Fundamental
  • Price
  • CVRX $13.91
  • DOMO $8.46
  • Analyst Decision
  • CVRX Buy
  • DOMO Hold
  • Analyst Count
  • CVRX 7
  • DOMO 5
  • Target Price
  • CVRX $15.83
  • DOMO $9.60
  • AVG Volume (30 Days)
  • CVRX 463.4K
  • DOMO 250.1K
  • Earning Date
  • CVRX 10-29-2024
  • DOMO 11-29-2024
  • Dividend Yield
  • CVRX N/A
  • DOMO N/A
  • EPS Growth
  • CVRX N/A
  • DOMO N/A
  • EPS
  • CVRX N/A
  • DOMO N/A
  • Revenue
  • CVRX $47,255,000.00
  • DOMO $318,369,000.00
  • Revenue This Year
  • CVRX $31.78
  • DOMO $0.39
  • Revenue Next Year
  • CVRX $26.70
  • DOMO N/A
  • P/E Ratio
  • CVRX N/A
  • DOMO N/A
  • Revenue Growth
  • CVRX 34.38
  • DOMO 0.19
  • 52 Week Low
  • CVRX $6.40
  • DOMO $6.11
  • 52 Week High
  • CVRX $33.14
  • DOMO $12.23
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 60.36
  • DOMO 53.66
  • Support Level
  • CVRX $13.59
  • DOMO $8.89
  • Resistance Level
  • CVRX $15.95
  • DOMO $9.26
  • Average True Range (ATR)
  • CVRX 1.13
  • DOMO 0.35
  • MACD
  • CVRX -0.09
  • DOMO 0.01
  • Stochastic Oscillator
  • CVRX 65.37
  • DOMO 44.87

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: